Catalog record · Risk Management
Stage as of Oct 29, 2026 · historical report, not live reconfirmation.
AI screening linked to case follow-up and outcome tracking
Vendor workflow source. A reviewed supplier account names the customer and workflow. Supplier attribution and deployment claims are not independent outcome validation.
Last researched Nov 8, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
Stamford's clinical pilot integrates AI ECG screening with a workflow tracking flagged patients through imaging, evaluation and treatment decisions.
- Reported stage
- Pilot
- Technology
- AI ECG waveform classification
- Business function
- Back Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Nov 8, 2026
- Last researched
- Nov 8, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Vendor says Pathway is the first algorithm partner to go live and describes the named Stamford pilot. Status as of 2026-10-29.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Future echo-completion and time-to-evaluation measurements are not reported outcomes. Earlier CardioCare patient counts are not attributable to this new ECG pilot. Publication is new in the research window; the exact original deployment date is not established unless stated. Cardiac algorithms and clinical accuracy do not transfer to financial data. Validate alert quality, case prioritization, investigator capacity and missed-case outcomes separately.
Potential FS application · inferred
Inference: Connect fraud or operational-risk alerts to case ownership, investigation steps and completion outcomes.
The transferable capability is closing the gap between model detection and completed expert follow-up, with end-to-end measurement.
Original industry: Healthcare delivery. Transfer limits: Cardiac algorithms and clinical accuracy do not transfer to financial data. Validate alert quality, case prioritization, investigator capacity and missed-case outcomes separately.
Recorded dependencies
- Permissioned data, workflow-specific evaluation and accountable human review.
Source register
- egnite, Pathway Labs and Stamford Health Launch First-of-Its-Kind Pilot Using ECG-Based AI to Help Clinicians Identify and Manage Structural Heart Patientsegnitehealth.com · opens in a new tab
egnite · vendor-case · full-text · Published 2026-10-29
Research lanes: cross-domain-refresh · Batch research-refresh-2026-11-08. Coverage and remaining gaps